Literature DB >> 25517383

Targeting mitochondria metabolism for cancer therapy.

Samuel E Weinberg1, Navdeep S Chandel1.   

Abstract

Mitochondria have a well-recognized role in the production of ATP and the intermediates needed for macromolecule biosynthesis, such as nucleotides. Mitochondria also participate in the activation of signaling pathways. Overall, accumulating evidence now suggests that mitochondrial bioenergetics, biosynthesis and signaling are required for tumorigenesis. Thus, emerging studies have begun to demonstrate that mitochondrial metabolism is potentially a fruitful arena for cancer therapy. In this Perspective, we highlight recent developments in targeting mitochondrial metabolism for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25517383      PMCID: PMC4340667          DOI: 10.1038/nchembio.1712

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  102 in total

Review 1.  Surviving antioxidant supplements.

Authors:  Goran Bjelakovic; Christian Gluud
Journal:  J Natl Cancer Inst       Date:  2007-05-16       Impact factor: 13.506

2.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.

Authors:  David R Wise; Ralph J DeBerardinis; Anthony Mancuso; Nabil Sayed; Xiao-Yong Zhang; Harla K Pfeiffer; Ilana Nissim; Evgueni Daikhin; Marc Yudkoff; Steven B McMahon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

3.  Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

Authors:  Ayako Tomimoto; Hiroki Endo; Michiko Sugiyama; Toshio Fujisawa; Kunihiro Hosono; Hirokazu Takahashi; Noriko Nakajima; Yoji Nagashima; Koichiro Wada; Hitoshi Nakagama; Atsushi Nakajima
Journal:  Cancer Sci       Date:  2008-09-18       Impact factor: 6.716

4.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

5.  c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

Authors:  Ping Gao; Irina Tchernyshyov; Tsung-Cheng Chang; Yun-Sil Lee; Kayoko Kita; Takafumi Ochi; Karen I Zeller; Angelo M De Marzo; Jennifer E Van Eyk; Joshua T Mendell; Chi V Dang
Journal:  Nature       Date:  2009-02-15       Impact factor: 49.962

6.  Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis.

Authors:  Robert D Guzy; Bhumika Sharma; Eric Bell; Navdeep S Chandel; Paul T Schumacker
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

7.  Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.

Authors:  Monica Buzzai; Russell G Jones; Ravi K Amaravadi; Julian J Lum; Ralph J DeBerardinis; Fangping Zhao; Benoit Viollet; Craig B Thompson
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

8.  ATP-citrate lyase links cellular metabolism to histone acetylation.

Authors:  Kathryn E Wellen; Georgia Hatzivassiliou; Uma M Sachdeva; Thi V Bui; Justin R Cross; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

9.  Targeting aspartate aminotransferase in breast cancer.

Authors:  Joshua Marshall Thornburg; Kristin K Nelson; Brian F Clem; Andrew N Lane; Sengodagounder Arumugam; Allan Simmons; John W Eaton; Sucheta Telang; Jason Chesney
Journal:  Breast Cancer Res       Date:  2008-10-15       Impact factor: 6.466

10.  Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.

Authors:  Jeffrey A Engelman; Liang Chen; Xiaohong Tan; Katherine Crosby; Alexander R Guimaraes; Rabi Upadhyay; Michel Maira; Kate McNamara; Samanthi A Perera; Youngchul Song; Lucian R Chirieac; Ramneet Kaur; Angela Lightbown; Jessica Simendinger; Timothy Li; Robert F Padera; Carlos García-Echeverría; Ralph Weissleder; Umar Mahmood; Lewis C Cantley; Kwok-Kin Wong
Journal:  Nat Med       Date:  2008-11-30       Impact factor: 53.440

View more
  413 in total

1.  Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma.

Authors:  Kei Satoh; Lisa Zhang; Yaqin Zhang; Raju Chelluri; Myriem Boufraqech; Naris Nilubol; Dhaval Patel; Min Shen; Electron Kebebew
Journal:  Clin Cancer Res       Date:  2016-02-12       Impact factor: 12.531

2.  Furoates and thenoates inhibit pyruvate dehydrogenase kinase 2 allosterically by binding to its pyruvate regulatory site.

Authors:  Tiziana Masini; Barbara Birkaya; Simon van Dijk; Milon Mondal; Johan Hekelaar; Manuel Jäger; Anke C Terwisscha van Scheltinga; Mulchand S Patel; Anna K H Hirsch; Edelmiro Moman
Journal:  J Enzyme Inhib Med Chem       Date:  2016-07-19       Impact factor: 5.051

3.  Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy.

Authors:  Szu-Yuan Li; Jihwan Park; Chengxiang Qiu; Seung Hyeok Han; Matthew B Palmer; Zoltan Arany; Katalin Susztak
Journal:  JCI Insight       Date:  2017-07-20

4.  Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone.

Authors:  Mei Li; Weidan Wang; Ye Zhu; Yao Lu; Peng Wan; Ke Yang; Yu Zhang; Chuanbin Mao
Journal:  Acta Biomater       Date:  2018-07-17       Impact factor: 8.947

5.  IACS-010759, a potent inhibitor of glycolysis-deficient hypoxic tumor cells, inhibits mitochondrial respiratory complex I through a unique mechanism.

Authors:  Atsuhito Tsuji; Takumi Akao; Takahiro Masuya; Masatoshi Murai; Hideto Miyoshi
Journal:  J Biol Chem       Date:  2020-04-14       Impact factor: 5.157

Review 6.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

7.  Do MCF7 cells cope with metformin treatment under energetic stress in low glucose conditions?

Authors:  Irem Dogan Turacli; Haldun Umudum; Arzu Pampal; Tuba Candar; Lara Kavasoglu; Yaren Sari
Journal:  Mol Biol Rep       Date:  2018-02-03       Impact factor: 2.316

Review 8.  Including the mitochondrial metabolism of L-lactate in cancer metabolic reprogramming.

Authors:  Lidia de Bari; Anna Atlante
Journal:  Cell Mol Life Sci       Date:  2018-05-04       Impact factor: 9.261

9.  More than a powerplant: the influence of mitochondrial transfer on the epigenome.

Authors:  Alexander N Patananan; Alexander J Sercel; Michael A Teitell
Journal:  Curr Opin Physiol       Date:  2017-12-13

Review 10.  VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.

Authors:  Diana Fang; Eduardo N Maldonado
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.